Tumour necrosis factor alpha in segmental colitis associated with diverticula

Digestive Diseases and Sciences

Volumn 53, Issue 7, 2008, Pages 1865-1868

  Ierardi, Enzo ^a   Meucci, Gianmichele ^b   Hassan, Cesare ^c   Zullo, Angelo ^c   Imperiali, Gianni ^b   De Francesco, Vincenzo ^a   Panella, Carmine ^a   Morini, Sergio ^c   Minoli, Giorgio ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b VALDUCE HOSPITAL   (Italy)

^c NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

Segmental colitis associated with diverticula; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLITIS; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DIVERTICULOSIS; EPITHELIUM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

AGED; AGED, 80 AND OVER; COLITIS; COLONOSCOPY; DIVERTICULUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44449117550     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0086-9     Document Type: Article

References (23)

1. Hughes LE (1969) Post-mortem survey of diverticular disease of the colon. 1. Diverticulosis and diverticulitis. Gut 10:336-344
2. Imperiali G, Meucci G, Alvisi C et al (2000) Segmental colitis associated with diverticula: a prospective study. Am J Gastroenterol 95:1014-1016
3. Koutroubakis IE, Antoniou P, Tzardi M et al (2005) The spectrum of segmental colitis associated with diverticulosis. Int J Colorectal Dis 20:28-32
4. Gledhill A, Dixon MF (1998) Crohn's-like reaction in diverticular disease. Gut 42:392-395
5. Shepherd NA (1996) Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades. Gut 38:801-802
6. Peppercorn MA (1992) Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol 87:609-612
7. Reimund JM, Wittersheim C, Dumont S et al (1996) Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 39:684-689
8. Murch SH, Lamkin VA, Savage MO et al (1991) Serum concentrations of tumour necrosis factor a in childhood chronic inflammatory bowel disease. Gut 32:913-917
9. Braegger CP, Nicholls S, Murch SH et al (1992) Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339:89-91
10. Reinecker H-C, Steffen M, Witthoeft T et al (1993) Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1b by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181
11. Plevy SE, Landers CJ, Prehn J et al (1997) A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 159:6276-6282
12. Berner B, Akca D, Jung T et al (2000) Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 27:1128-1135
13. Murch SH, Braegger CP, Walker-Smith JA et al (1993) Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34:1705-1709
14. Hassan C, Ierardi E, Burattini O et al (2007) tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. Dig Liver Dis 39:811-817
15. Knight DM, Trinh H, Le J et al (1993) Construction and initial characterization of a mouse-human chimeric anti-TNF-antibody. Mol Immunol 30:1443-1453
16. Rutgeerts P, Sandborn WJ, Feagan BG et al (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462-2476
17. Hanauer SB, Feagan BG, Lichtenstein GR et al (2002) Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359:1541-1549
18. Sands BE, Anderson FH, Bernstein CN et al (2004) Infliximab maintenance therapy for fistulising Crohn's disease. N Engl J Med 350:876-885
19. Baert FJ, D'Haens GR, Peeters M et al (1999) tumour necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116:22-28
20. Hassan C, Zullo A, Ierardi E et al (2006) Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula. Gut 55:589-590
21. Imperiali G, Terpin MM, Meucci G et al (2006) Segmental colitis associated with diverticula: a 7-year follow-up study. Endoscopy 38:610-612
22. Morson BC, Dawson IMP (1979) Gastro-intestinal pathology, 2nd edn. Blackwell Scientific Publications, Oxford, pp 530-533
23. Ierardi E, Monno RA, Gentile A et al (2001) Helicobacter heilmannii gastritis: a histological and immunohistochemical trait. J Clin Pathol 54:774-777